CorMedix(CRMD) - 2024 Q4 - Annual Results

Financial Results - CorMedix Inc. announced preliminary financial results for Q4 and the year ended December 31, 2024[4]. - The press release detailing these results was issued on January 7, 2025[4]. - The report does not include specific financial metrics or performance indicators[4]. - The report does not provide future guidance or performance outlook[4]. Company Information - The company is listed on the Nasdaq Global Market under the trading symbol CRMD[2]. - The company is not classified as an emerging growth company under the Securities Act[3]. - The report is intended to comply with the requirements of the Securities Exchange Act of 1934[5]. - The financial statements and exhibits related to the report are included as Exhibit 99.1 and Exhibit 104[7]. Management - The company’s CEO, Joseph Todisco, signed the report[11]. Product and Strategy - There is no mention of new product development or market expansion strategies in the provided content[4].